Human Leucocyte Antigen-A2 Restricted and Mycobacterium Tuberculosis 19-kDa Antigen-specific CD8+ T-cell Responses Are Oligoclonal and Exhibit a T-cell Cytotoxic Type 2 Response Cytokine-secretion Pattern

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 2001 Nov 28

PMID 11722642

Citations 6

Authors

H Hohn

C Kortsik

K Nilges

A Necker

K Freitag

G Tully

C Neukirch

M J Maeurer

Affiliations

Soon will be listed here.

Abstract

CD8+ T cells can be grouped into two different types of secretory T lymphocytes, based on the cytokine-secretion pattern upon antigen exposure: those with a T-cell cytotoxic type 1 response (Tc1), which secrete interferon-gamma (IFN-gamma), or those with a T-cell cytotoxic type 2 response, which secrete interleukin (IL)-4 and IL-10. We examined the CD8+ T-cell response directed against an immunodominant human leucocyte antigen (HLA)-A2-presented peptide derived from a 19-kDa Mycobacterium tuberculosis-associated antigen. T cells were examined by functional analysis and by T-cell receptor (TCR) complementarity-determining region 3 (CDR3)-spectratyping, which defines the complexity of a T-cell response. T-cell stimulation with the immunodominant VLTDGNPPEV epitope yielded a Tc2 (IL-4) cytokine-secretion pattern and resulted in oligoclonal expansion of TCR-variable beta chain (VB) families, which differed from patient to patient. Generation of T-cell clones corroborated the notion that the CD8+ T-cell response directed against the HLA-A2-presented VLTDGNPPEV epitope leads to a Tc2 cytokine-secretion pattern in CD8+ T cells, as defined by IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF) release. Characterization of the cytokine-secretion profile in HLA-A2/VLTDGNPPEV-tetramer sorted T cells from patients with active tuberculosis supported this observation: peptide-specific T cells from three of three patients secreted IL-4 and only one of three patients produced IFN-gamma in response to the nominal target epitope. Permutation of this T-cell epitope may aid to elicit a qualitatively different CD8+ T-cell response in patients with M. tuberculosis infection.

Citing Articles

Peptide-Based Vaccines for Tuberculosis.

Gong W, Pan C, Cheng P, Wang J, Zhao G, Wu X Front Immunol. 2022; 13:830497.

PMID: 35173740 PMC: 8841753. DOI: 10.3389/fimmu.2022.830497.

High content cellular immune profiling reveals differences between rhesus monkeys and men.

Magalhaes I, Vudattu N, Ahmed R, Kuhlmann-Berenzon S, Ngo Y, Sizemore D Immunology. 2010; 131(1):128-40.

PMID: 20465573 PMC: 2966765. DOI: 10.1111/j.1365-2567.2010.03284.x.

Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients.

Serana F, Sottini A, Caimi L, Palermo B, Natali P, Nistico P J Transl Med. 2009; 7:21.

PMID: 19317896 PMC: 2667493. DOI: 10.1186/1479-5876-7-21.

Conserved mycobacterial lipoglycoproteins activate TLR2 but also require glycosylation for MHC class II-restricted T cell activation.

Sieling P, Hill P, Dobos K, Brookman K, Kuhlman A, Fabri M J Immunol. 2008; 180(9):5833-42.

PMID: 18424702 PMC: 2710377. DOI: 10.4049/jimmunol.180.9.5833.

Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Woodworth J, Behar S Crit Rev Immunol. 2006; 26(4):317-52.

PMID: 17073557 PMC: 3134450. DOI: 10.1615/critrevimmunol.v26.i4.30.

References

Yeremeev V, Lyadova I, Nikonenko B, Apt A, Inwald J, Young D . The 19-kD antigen and protective immunity in a murine model of tuberculosis. Clin Exp Immunol. 2000; 120(2):274-9. PMC: 1905638. DOI: 10.1046/j.1365-2249.2000.01212.x. View

Esin S, Batoni G, Saruhan-Direskeneli G, Harris R, Grunewald J, Pardini M . In vitro expansion of T-cell-receptor Valpha2.3(+) CD4(+) T lymphocytes in HLA-DR17(3), DQ2(+) individuals upon stimulation with Mycobacterium tuberculosis. Infect Immun. 1999; 67(8):3800-9. PMC: 96657. DOI: 10.1128/IAI.67.8.3800-3809.1999. View

Jager E, Maeurer M, Hohn H, Karbach J, Jager D, Zidianakis Z . Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides. Int J Cancer. 2000; 86(4):538-47. DOI: 10.1002/(sici)1097-0215(20000515)86:4<538::aid-ijc16>3.0.co;2-g. View

Bodinier M, Peyrat M, Tournay C, Davodeau F, Romagne F, Bonneville M . Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding. Nat Med. 2000; 6(6):707-10. DOI: 10.1038/76292. View

Lewinsohn D, Briden A, Reed S, Grabstein K, Alderson M . Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction. J Immunol. 2000; 165(2):925-30. DOI: 10.4049/jimmunol.165.2.925. View

Hohn H, Reichert T, Neukirch C, Pilch H, Maeurer M . Monoclonal TCR mRNA transcripts are preferentially detected in the TCR variable alpha chain in CD8(+) T-lymphocytes: implications for immunomonitoring. Int J Mol Med. 1999; 3(2):139-44. DOI: 10.3892/ijmm.3.2.139. View

Geluk A, van Meijgaarden K, Franken K, Drijfhout J, DSouza S, Necker A . Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J Immunol. 2000; 165(11):6463-71. DOI: 10.4049/jimmunol.165.11.6463. View

Liu H, Rhodes M, Wiest D, Vignali D . On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity. 2000; 13(5):665-75. DOI: 10.1016/s1074-7613(00)00066-2. View

Smith S, Brookes R, Klein M, Malin A, Lukey P, King A . Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A. J Immunol. 2000; 165(12):7088-95. DOI: 10.4049/jimmunol.165.12.7088. View

10.

Skeiky Y, Ovendale P, Jen S, Alderson M, Dillon D, Smith S . T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection. J Immunol. 2000; 165(12):7140-9. DOI: 10.4049/jimmunol.165.12.7140. View

11.

Lewinsohn D, Zhu L, Madison V, Dillon D, Fling S, Reed S . Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity. J Immunol. 2000; 166(1):439-46. DOI: 10.4049/jimmunol.166.1.439. View

12.

Post F, Manca C, Neyrolles O, Ryffel B, Young D, Kaplan G . Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro. Infect Immun. 2001; 69(3):1433-9. PMC: 98038. DOI: 10.1128/IAI.69.3.1433-1439.2001. View

13.

Langenkamp A, Messi M, Lanzavecchia A, Sallusto F . Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol. 2001; 1(4):311-6. DOI: 10.1038/79758. View

14.

Barnes P, Fong S, Brennan P, Twomey P, Mazumder A, Modlin R . Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol. 1990; 145(1):149-54. View

15.

Moss P, Moots R, Rosenberg W, BODMER H, McMichael A, Bell J . Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci U S A. 1991; 88(20):8987-90. PMC: 52636. DOI: 10.1073/pnas.88.20.8987. View

16.

Ashbridge K, Backstrom B, Liu H, Vikerfors T, Englebretsen D, Harding D . Mapping of T helper cell epitopes by using peptides spanning the 19-kDa protein of Mycobacterium tuberculosis. Evidence for unique and shared epitopes in the stimulation of antibody and delayed-type hypersensitivity responses. J Immunol. 1992; 148(7):2248-55. View

17.

Barnes P, Chatterjee D, Abrams J, Lu S, Wang E, Yamamura M . Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol. 1992; 149(2):541-7. View

18.

Flynn J, GOLDSTEIN M, Triebold K, Koller B, Bloom B . Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A. 1992; 89(24):12013-7. PMC: 50688. DOI: 10.1073/pnas.89.24.12013. View

19.

Kaufmann S . Immunity to intracellular bacteria. Annu Rev Immunol. 1993; 11:129-63. DOI: 10.1146/annurev.iy.11.040193.001021. View

20.

Flynn J, Chan J, Triebold K, Dalton D, Stewart T, Bloom B . An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993; 178(6):2249-54. PMC: 2191274. DOI: 10.1084/jem.178.6.2249. View